DNASE1L2
Basic information
Region (hg38): 16:2235816-2238711
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DNASE1L2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 20 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 20 | 0 | 0 |
Variants in DNASE1L2
This is a list of pathogenic ClinVar variants found in the DNASE1L2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-2236888-C-G | not specified | Uncertain significance (Nov 25, 2024) | ||
16-2236913-G-T | not specified | Uncertain significance (Nov 18, 2023) | ||
16-2237066-T-C | not specified | Uncertain significance (Jul 12, 2022) | ||
16-2237111-T-A | not specified | Uncertain significance (Nov 30, 2021) | ||
16-2237118-G-C | not specified | Uncertain significance (Sep 09, 2024) | ||
16-2237249-A-G | not specified | Uncertain significance (Jan 05, 2022) | ||
16-2237267-G-A | not specified | Uncertain significance (Sep 15, 2021) | ||
16-2237378-A-G | not specified | Uncertain significance (Jan 22, 2024) | ||
16-2237524-C-T | not specified | Uncertain significance (Nov 14, 2024) | ||
16-2237540-C-T | not specified | Uncertain significance (May 28, 2024) | ||
16-2237569-G-C | not specified | Uncertain significance (Apr 20, 2024) | ||
16-2237572-G-C | not specified | Uncertain significance (Jun 18, 2021) | ||
16-2237587-G-T | not specified | Uncertain significance (Sep 02, 2024) | ||
16-2237645-C-T | not specified | Uncertain significance (Nov 24, 2024) | ||
16-2237771-T-C | not specified | Uncertain significance (Oct 01, 2024) | ||
16-2237884-G-A | not specified | Uncertain significance (May 31, 2023) | ||
16-2237938-G-A | not specified | Uncertain significance (Oct 20, 2023) | ||
16-2237972-C-G | not specified | Uncertain significance (Sep 17, 2021) | ||
16-2237984-A-C | not specified | Uncertain significance (Jul 14, 2021) | ||
16-2238369-C-T | not specified | Uncertain significance (Sep 20, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DNASE1L2 | protein_coding | protein_coding | ENST00000564065 | 6 | 2896 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.32e-7 | 0.343 | 123828 | 0 | 176 | 124004 | 0.000710 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.341 | 200 | 187 | 1.07 | 0.00000959 | 1890 |
Missense in Polyphen | 79 | 79.569 | 0.99285 | 845 | ||
Synonymous | 0.113 | 84 | 85.3 | 0.985 | 0.00000481 | 604 |
Loss of Function | 0.520 | 11 | 13.0 | 0.844 | 6.29e-7 | 124 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00308 | 0.00276 |
Ashkenazi Jewish | 0.000329 | 0.000300 |
East Asian | 0.00103 | 0.00100 |
Finnish | 0.000291 | 0.000279 |
European (Non-Finnish) | 0.000549 | 0.000508 |
Middle Eastern | 0.00103 | 0.00100 |
South Asian | 0.00108 | 0.00105 |
Other | 0.000533 | 0.000498 |
dbNSFP
Source:
- Function
- FUNCTION: Divalent cation-dependent acid DNA endonuclease involved in the breakdown of the nucleus during corneocyte formation of epidermal keratinocytes. May play an immune role by eliminating harmful DNA released into the extracellular environment by damaged epidermal cells. {ECO:0000269|PubMed:16902420}.;
Recessive Scores
- pRec
- 0.181
Intolerance Scores
- loftool
- 0.532
- rvis_EVS
- -0.09
- rvis_percentile_EVS
- 46.74
Haploinsufficiency Scores
- pHI
- 0.0300
- hipred
- N
- hipred_score
- 0.303
- ghis
- 0.578
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.161
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dnase1l2
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; skeleton phenotype; renal/urinary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; digestive/alimentary phenotype; vision/eye phenotype; immune system phenotype;
Gene ontology
- Biological process
- DNA catabolic process, endonucleolytic;hair follicle development;corneocyte development;DNA metabolic process;DNA catabolic process
- Cellular component
- extracellular region;nucleus;cytoplasm
- Molecular function
- DNA binding;deoxyribonuclease I activity;deoxyribonuclease activity;calcium ion binding